The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initiation of high dose chemotherapy at rising tumor markers compared with radiographic progression in patients with relapsed germ-cell tumors (GCT).
 
Rebecca Hassoun
Research Funding - Natera (Inst)
 
Rafat Abonour
Honoraria - Johnson & Johnson/Janssen; Pfizer
Consulting or Advisory Role - BMS (Inst); Janssen Oncology; pfizer; Sanofi; Takeda
Speakers' Bureau - Johnson & Johnson/Janssen; Pfizer
Research Funding - Janssen (Inst)
 
Sandra Althouse
No Relationships to Disclose
 
Tareq Salous
Research Funding - Alliance for Clinical Trials in Oncology (Inst)
 
Jennifer King
No Relationships to Disclose
 
Lawrence Einhorn
Stock and Other Ownership Interests - Amgen
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; EMD Serono; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst); Natera (Inst)